

Prostate cancer is one of the most common cancers in men, and early detection is critical. The PSA (prostate-specific antigen) test is often the first step in the screening process. But while PSA testing has helped detect cancer in many patients, it also has significant limitations—and relying on it alone can be misleading.
Here’s what you need to know.
The PSA test measures the level of prostate-specific antigen, a protein produced by the prostate gland, in your blood. Elevated levels may indicate prostate cancer—but can also result from non-cancerous conditions such as:
Because of this, PSA results are not a definitive diagnosis.
An elevated PSA level doesn’t always mean cancer is present. This can lead to unnecessary biopsies, which carry their own risks—such as infection, bleeding, or complications from anesthesia.
Some men with prostate cancer have normal PSA levels. This means the cancer could go undetected and progress before symptoms appear.
PSA testing often detects slow-growing tumors that may never cause symptoms or affect lifespan. Still, many men choose to undergo surgery or radiation, which can cause side effects like urinary incontinence or erectile dysfunction—even when treatment may not have been necessary.
PSA testing can be a helpful first step, but it’s only part of the picture. That’s why many providers—including those at Gregory Rhodes MD Cancer Center—recommend combining PSA tests with:
These tools help provide a more accurate diagnosis and reduce the chances of unnecessary treatment.
Not all men face the same risk of prostate cancer. You may need more frequent screening if you:
At Gregory Rhodes MD Cancer Center, we believe in informed decisions and personalized care. If you're due for screening—or want a second opinion on your PSA results—our urology and oncology teams are here to help.
Call us at (925) 433-8786 or visit Gregory Rhodes MD Cancer Center to schedule your consultation.